Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Aug
23
2023
Fifth Circuit Court Keeps Abortion Medication Legal, But with Restrictions Dinsmore & Shohl LLP
Aug
23
2023
CRS Updates Report on USDA’s SECURE Rule to Regulate Agricultural Biotechnology Bergeson & Campbell, P.C.
Aug
22
2023
Concurrence Raises Questions Regarding the Application of Primary Jurisdiction in State Court Keller and Heckman LLP
Aug
22
2023
EPA Will Hold Webinar on Reviews of New PFAS and New Uses of Existing PFAS Bergeson & Campbell, P.C.
Aug
22
2023
D&O Can Be a Source of Coverage for Opioid Suits Hunton Andrews Kurth
Aug
22
2023
Top Takeaways | 2023 Physician Practice Management & ASC Symposium | Maximizing Managed Practice Value & Operations McDermott Will & Emery
Aug
21
2023
Fifth Circuit Supports Restrictions on Medication Abortion, But No Immediate Impact on Group Health Plans (For Now) Proskauer Rose LLP
Aug
21
2023
2023 Update on Alabama Alcohol Laws Bradley Arant Boult Cummings LLP
Aug
21
2023
Court Again Stays Alabama Medical Cannabis Program: The Song Remains the Same Bradley Arant Boult Cummings LLP
Aug
21
2023
Legal Implications of AI in the Life Sciences Industry ArentFox Schiff LLP
Aug
21
2023
Splenda is Again the Subject of Legal News Keller and Heckman LLP
Aug
18
2023
FDA Responds to CSPI’s Sesame Allergen Labeling Petition Keller and Heckman LLP
Aug
17
2023
PFAS EPA Enforcement A Priority (Officially) CMBG3 Law
Aug
17
2023
Fifth Circuit Rules to Reinstate Abortion Pill Restrictions Sheppard, Mullin, Richter & Hampton LLP
Aug
17
2023
Settlement Reached in Transshipping Pork Issue in Massachusetts Keller and Heckman LLP
Aug
17
2023
Fourth Circuit Holds Catch-and-Release Fishing Not Regulated by Federal Clean Water Act ArentFox Schiff LLP
Aug
17
2023
ICIS Innovation Awards Recognize Sustainability in Chemical Industry Bergeson & Campbell, P.C.
Aug
16
2023
FDA Seeks Input on Citizen Petition Regarding Pasteurized Orange Juice Keller and Heckman LLP
Aug
16
2023
COFEPRIS Secure Cannabis Based Products. OLIVARES
Aug
16
2023
Fifth Circuit Upholds Marijuana User’s Second Amendment Rights – Will the Eleventh Circuit Do the Same? Bradley Arant Boult Cummings LLP
Aug
16
2023
UK Calls for Data on Nanomaterials in Cosmetics Bergeson & Campbell, P.C.
Aug
15
2023
Chew on this…Xylazine Legislation Is Here Womble Bond Dickinson (US) LLP
Aug
15
2023
9th Circuit Affirms that Challenges to Allegedly Misleading Protein Claims Preempted Keller and Heckman LLP
Aug
15
2023
FDA Finalizes Informed Consent Guidance for Drug and Medical Device Clinical Investigations Nelson Mullins
Aug
15
2023
Federal Court Vacates FDA Deeming of Premium Cigars Subject to the Tobacco Control Act Keller and Heckman LLP
Aug
15
2023
How Close Can You Be to Cannabis and Still Have Access to the Bankruptcy Courts? (US) Squire Patton Boggs (US) LLP
Aug
15
2023
Tea Parties Certified For Class Action K&L Gates
Aug
14
2023
Alabama Medical Cannabis Commission Awards 24 Licenses, Appeals to Follow Bradley Arant Boult Cummings LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins